Skip to main content

Animations

Browse current and past press releases from The Michael J. Fox Foundation.

From
To
  • Default content image

    Michael J. Fox Foundation Partnering on Program to Expand Molecular Investigation of Parkinson's Disease

    MJFF a partner in National Institutes of Health public-private Accelerating Medicines Partnership Parkinson's Disease (AMP PD) program. Program funds investigation of data and biosamples from MJFF…
    Learn more Save for later

  • Default content image

    Michael J. Fox Foundation Study Demonstrates Feasibility of Wearable Devices in Parkinson's Research and Care

    NEW YORK (December 20, 2017) -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) today released data from the Parkinson@Home Study. Researchers demonstrated the feasibility of collecting…
    Learn more Save for later

  • Default content image

    Protein Levels in Spinal Fluid Correlate to Posture and Gait Difficulty in Parkinson's Disease

    Study sponsored by The Michael J. Fox Foundation for Parkinson's Research found lower alpha-synuclein levels in spinal fluid associated with postural instability/gait difficulty phenotype. Beta…
    Learn more Save for later

  • Default content image

    Michael J. Fox Foundation Honors Andres Lozano, MD, PhD, with Bachmann-Strauss Prize for Excellence in Dystonia Research

    NEW YORK (November 13, 2017) -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) announced Andres Lozano, MD, PhD, professor of neurosurgery at the University of Toronto and Toronto…
    Learn more Save for later

  • Default content image

    Michael J. Fox Foundation Honors Ken Marek, MD, with Robert A. Pritzker Prize for Leadership in Parkinson's Research

    NEW YORK (November 13, 2017) -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) has awarded the 2017 Robert A. Pritzker Prize for Leadership in Parkinson's Research to Ken Marek, MD,…
    Learn more Save for later

  • Default content image

    Enrollment Now Open for The Michael J. Fox Foundation Phase IIa Clinical Trial Investigating Nilotinib in Parkinson's Disease

    Enrollment will open on an ongoing basis at a maximum of 25 clinical sites across the United States Visit foxtrialfinder.org for a list of currently recruiting sites and eligibility criteria Patients…
    Learn more Save for later

  • Default content image

    Michael J. Fox Foundation and 23andMe Announce Collaboration to Capture Parkinson's Experience at Scale and Amplify Patient Voice in Research and Care

    Fox Insight online digital platform facilitates partnership between patients and researchers to accelerate improved Parkinson's treatments and care Collaboration with 23andMe marries genetic and…
    Learn more Save for later

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.